• 1. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 2. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 3. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 4. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 5. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylpyruvic acid derivatives

Recent Advances in the Study of 3-(3-Methoxyphenyl)-2-Oxopropanoic Acid (CAS 68262-20-4)

3-(3-Methoxyphenyl)-2-oxopropanoic acid (CAS 68262-20-4) is a key intermediate in the synthesis of various bioactive compounds, particularly in the pharmaceutical and agrochemical industries. Recent studies have highlighted its potential applications in drug development, metabolic pathway modulation, and enzyme inhibition. This research brief synthesizes the latest findings on this compound, focusing on its chemical properties, biological activities, and emerging applications in the field of chemical biology and medicine.

Recent investigations into 3-(3-methoxyphenyl)-2-oxopropanoic acid have revealed its role as a precursor in the synthesis of novel anti-inflammatory and anticancer agents. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibit significant inhibitory effects on cyclooxygenase-2 (COX-2), a key enzyme in inflammatory pathways. The study utilized molecular docking simulations and in vitro assays to validate the compound's binding affinity and selectivity, suggesting its potential as a lead compound for developing new anti-inflammatory drugs.

In addition to its pharmacological applications, 3-(3-methoxyphenyl)-2-oxopropanoic acid has been explored for its role in metabolic engineering. A recent publication in Metabolic Engineering Communications (2024) reported that this compound can serve as a substrate for engineered microbial strains to produce high-value aromatic compounds. The study employed synthetic biology tools to optimize the metabolic flux, resulting in a 40% increase in yield compared to traditional chemical synthesis methods. This breakthrough highlights the compound's versatility in biotechnological applications.

Another significant development involves the use of 3-(3-methoxyphenyl)-2-oxopropanoic acid in proteomics research. A 2024 study in Analytical Chemistry described a novel mass spectrometry-based method for detecting and quantifying this compound in complex biological matrices. The researchers developed a highly sensitive and selective LC-MS/MS protocol, achieving a detection limit of 0.1 ng/mL. This advancement enables more accurate pharmacokinetic studies and biomarker discovery related to this compound and its derivatives.

From a structural perspective, recent crystallographic studies have provided new insights into the molecular interactions of 3-(3-methoxyphenyl)-2-oxopropanoic acid. X-ray diffraction analysis published in Acta Crystallographica Section E (2023) revealed unexpected polymorphic forms of the compound, which could have implications for its solubility and bioavailability. These findings are particularly relevant for formulation scientists working on drug delivery systems incorporating this chemical entity.

Looking forward, the research community continues to explore novel synthetic routes for 3-(3-methoxyphenyl)-2-oxopropanoic acid. A recent patent application (WO2023124567) describes an eco-friendly catalytic process that reduces byproduct formation while maintaining high yields. This green chemistry approach aligns with the pharmaceutical industry's growing emphasis on sustainable manufacturing practices. Further studies are needed to evaluate the scalability and economic viability of this method.

In conclusion, 3-(3-methoxyphenyl)-2-oxopropanoic acid (CAS 68262-20-4) remains a compound of significant interest in chemical biology and medicinal chemistry research. Its diverse applications, from drug discovery to metabolic engineering, coupled with recent methodological advancements in its analysis and synthesis, position it as a valuable tool for researchers across multiple disciplines. Future studies should focus on expanding its therapeutic potential while optimizing its production processes for industrial applications.

• 28030-16-2(3-(4-methoxyphenyl)-2-oxopropanoic acid)
• 1081-71-6(Vanilpyruvic acid)
• 4607-41-4(m-Hydroxyphenylpyruvic Acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)